ABOUT US
Company Introduction
CEO Message
Business Strategy
Company History
Location
PIPELINE
Core Drug
Progress
RGN-259
Neurotrophic Keratitis
Dry Eye Disease
OKN-007
Glioblastoma Multiforme
BUSINESS
Cold Chain
Business Introduction
Status of Distribution Center
ESG
Sustainability Management
CEO ESG Message
ESG Implementation System
ESG Vision & Core Strategic Objectives
ESG Policy
ESG Policy
ESG Policy Archive
EHS Management
Environmental Policy
Safety & Health
Environmental Campaign
Talent Management
Human Rights Management
Welfare
Governance Structure
Shareholders
Board of Directors
Article of Incorporate
Ethical Management
Anti-Corruption Management
Others
Initiative
IR
Disclosure
IR Archive
PR
Notice
Press Release
CAREERS
EN
KR
Family Site
Subsidiary
Gtree Pharmaceuticals
Coreindus
ReGenTree
Oblato
Pharma·Bio
HLB
HLB Healthcare Business Department HLB Healthcare Division
HLB Life Science
HLB PHARMA
HLB Biostep
HLB Cell
HLB SCIENCE
Elevar Terapeutics
Immunomic Therapeutics
Verismo Therapeutics
Hwajinmedical
Shinhwa Advance
HLB Panagene
HLB Genex
HLB Pep
Ship · Plant · Energy
HLB GLOBAL
HLB ENG
HLB Networks
HLB Energy
Bada Heavy Industries
HLB Innovation
Life · Health · Leisure
HLB Life & Healthcare
FRESHICO
Hyundai Yachts
Hyundai Yachts Hyundai Cosmos Yachting
Penguin Ocean Leisure
HLB F&B
Finance
HLB Investment
PR
PR
소규모합병 채권자 이의제출 공고문
Date
2023-07-28
View
249
Prev
소규모합병 채권자 이의제출 안내
Next
합병종료 보고의 공고
List
